{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:59:24Z","timestamp":1785787164676,"version":"3.56.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.mbc.0000114442.59147.8d","type":"journal-article","created":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T04:00:48Z","timestamp":1087358448000},"page":"393-397","source":"Crossref","is-referenced-by-count":14,"title":["Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis"],"prefix":"10.1097","volume":"15","author":[{"given":"Elizabeth M","family":"Van Cott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Laposata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archopht.1994.01090180088041","article-title":"Antiphospholipid antibodies in retinal vascular occlusions: A prospective study of 75 patients.","volume":"112","author":"Glacet-Bernard","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9394(14)72969-1","article-title":"Antiphospholipid antibody syndrome associated with microscotomata.","volume":"118","author":"Hartnett","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00947091","article-title":"Retinal neovascularization in a case of macular branch retinal vein occlusion.","volume":"235","author":"Virgili","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0161-6420(88)33139-8","article-title":"Visual symptoms associated with the presence of a lupus anticoagulant.","volume":"95","author":"Levine","year":"1988","journal-title":"Ophthalmology"},{"key":"R5-4-20210203","first-page":"197","article-title":"AM, Al-Momen AK, al-Amro S, Abdel Gader AG, Tabbara KF. Prothrombotic states associated with retinal venous occlusion in young adults.","volume":"20","year":"1996","journal-title":"Int Ophthalmol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0887-8994(93)90027-A","article-title":"Primary antiphospholipid syndrome and neurologic events.","volume":"9","author":"Rumi","year":"1993","journal-title":"Pediatr Neurol"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9394(14)73919-4","article-title":"Hyperhomocysteinemia in retinal artery and retinal vein occlusion.","volume":"115","author":"Wenzler","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9394(00)00884-9","article-title":"Ocular features associated with anticardiolipin antibodies: a descriptive study.","volume":"131","author":"Miserocchi","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s004170050138","article-title":"Ocular symptoms in association with antiphospholipid antibodies.","volume":"236","author":"Leo-Kottler","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(01)00842-9","article-title":"Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years old.","volume":"109","author":"Lahey","year":"2002","journal-title":"Ophthalmology"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0037-1616130","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion.","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb Haemost"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(99)00074-4","article-title":"Retinal vascular occlusion and deficiencies in the protein C pathway.","volume":"128","author":"Greiner","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1034\/j.1600-0420.1999.770604.x","article-title":"Protein C, protein S and antithrombin III deficiencies in retinal vein occlusions.","volume":"77","author":"Tekeli","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9394(99)00311-6","article-title":"Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study.","volume":"128","author":"Cobo-Soriano","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bjo.85.11.1313","article-title":"Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.","volume":"85","author":"Boyd","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0420.2000.078003340.x","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.","volume":"78","author":"Larsson","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-3848(99)00111-5","article-title":"The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism P1A2 in patients with central retinal vein occlusion.","volume":"96","author":"Larsson","year":"1999","journal-title":"Thromb Res"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archopht.116.5.577","article-title":"Activated protein C resistance, factor V Leiden and central retinal vein occlusion in young adults.","volume":"116","author":"Gottlieb","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/eye.1995.191","article-title":"Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion.","volume":"9","author":"Hodgkins","year":"1995","journal-title":"Eye"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/eye.1991.10","article-title":"Vaso-occlusive retinopathy in the primary anti-phospholipid antibody syndrome.","volume":"5","author":"Acheson","year":"1991","journal-title":"Eye"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0889-857X(05)70351-3","article-title":"Antiphospholipid antibody syndrome in pediatric patients.","volume":"23","author":"Ravelli","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1076\/ocii.6.4.269.4025","article-title":"The clinico-ophthalmological spectrum of antiphospholipid syndrome.","volume":"6","author":"Giorgi","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome.","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archinte.158.8.862","article-title":"Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.","volume":"158","author":"Wald","year":"1998","journal-title":"Arch Intern Med"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0038-1650680","article-title":"Hyperhomocysteinemia and deep-vein thrombosis. A case control study.","volume":"76","author":"Simioni","year":"1996","journal-title":"Thromb Haemost"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1034\/j.1600-0420.1999.770606.x","article-title":"Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion.","volume":"77","author":"Larsson","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome.","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the anti-phospholipid antibody syndrome.","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0039-6257(78)90132-7","article-title":"Retinal branch vein occlusion.","volume":"22","author":"Orth","year":"1978","journal-title":"Surv Ophthalmol"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions.","volume":"100","author":"Frangieh","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00006982-198707040-00011","article-title":"Branch retinal vein occlusion: a clinicopathologic case report.","volume":"7","author":"Bowers","year":"1987","journal-title":"Retina"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mbc.0000114442.59147.8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:06:08Z","timestamp":1785783968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200407000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000114442.59147.8d","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}